BEAM
$23.47-5.10%
Beam Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.005%Russell 3000 0.004%
BEAM — Beam Therapeutics Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
20.030.040.050.060.070.080.090.0100.0110.0010.0M20.0M$23.47—20202021202320252026
2026-10-16
Price$23.47
MA20$27.24
MA50$28.23
Vol5.1M
Key stats#
Price data
- Price
- $23.47
- YTD price return
- -15.33%
- YTD total return
- -15.33%
- Next earnings
- Nov 3, 2026
- Market cap
- 2.4B
- Enterprise value
- 1.5B
- Shares outstanding
- 103.3M
- 52W low
- $20.23
- 52W high
- $38.26
- From 52W high
- -38.66%
- From 52W low
- +16.02%
- 52W range
- 18%
Volume
- Rel volume
- 0.82×
- 30D volume
- 2M
- 30D $ vol
- 49.8M
Fundamentals
- Sales (ttm)
- 156M
- Sales/share
- $1.51
- EPS (ttm)
- -$0.83
- FCF (ttm)
- -372.8M
- FCF/share
- -$3.61
- Book value/share
- $10.33
- Net margin
- -54.75%
- ROE
- -8.00%
- ROA
- -6.16%
- Debt / equity
- 0.09×
- Current ratio
- 14.57
Growth (CAGR, ttm) · 10Y
- Sales
- +159.05%+24.85%+479.04%n/a
- Shares
- +2.10%+9.25%+9.26%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +153.72%+14.28%+429.98%n/a
- Book value/share
- -0.74%+0.28%+4.57%n/a
- Price
- -9.00%+1.70%-24.09%n/a
- Total return
- -9.00%+1.70%-24.09%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -28.4×
- Fwd P/E
- -5.5×
- P/S (ttm)
- 15.5×
- P/B (mrq)
- 2.3×
- EV/Sales (ttm)
- 9.5×
- FCF yield (ttm)
- -15.38%
- Buyback yield (realized, 1y)
- -2.10%
- Shareholder yield (realized, 1y)
- -2.10%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 15th
- P/B
- 16th
Bar = where today’s multiple sits in BEAM’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-16#
1D
-5.10%
5D
-8.68%
1M
+1.60%
3M
-17.33%
YTD
-15.33%
1Y
-9.00%
5Y
-74.80%
Financial statements
Open full BEAM financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +10.48% | +0.43% |
| JNJ | Johnson & Johnson | -4.38% | +0.90% |
| ABBV | AbbVie Inc. | +8.73% | +0.71% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +6.97% | -1.29% |
| MRK | Merck & Co. Inc. | +0.72% | +0.52% |
| NVS | Novartis AG | +8.59% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +6.41% | -0.93% |
| AMGN | Amgen Inc. | +14.92% | -0.35% |
